Michael A. Cerra
Impact in
- Genetics top 10%
- Glioma Diagnosis and Treatment
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Blood Coagulation and Thrombosis Mechanisms 3
-
- DNA Repair Mechanisms 3
- Epigenetics and DNA Methylation 3
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
- RNA modifications and cancer 1
- Co-authors
- Philip J. Tofilon (8 shared papers)William E. Burgan (8 shared papers)Kevin A. Camphausen (8 shared papers)Kelli A. Oswald (3 shared papers)David Cerna (2 shared papers)Jeffery Scott Russell (3 shared papers)Jane B. Trepel (1 shared paper)Min-Jung Lee (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Molecular Cancer Therapeutics (2 papers)Antiviral Therapy (1 paper)Cancer Research (1 paper)European Heart Journal (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Michael A. Cerra
13 papers receiving 948 citations
Peers
Comparison fields: 5 of 62
- Genetics 169
- Hematology 117
- Internal Medicine 31
- Molecular Biology 600
- Oncology 185
Countries citing papers authored by Michael A. Cerra
This map shows the geographic impact of Michael A. Cerra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Cerra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Cerra more than expected).
Fields of papers citing papers by Michael A. Cerra
This network shows the impact of papers produced by Michael A. Cerra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Cerra. The network helps show where Michael A. Cerra may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael A. Cerra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 191 | |
| 2 | 2004 | 180 | |
| 3 | Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. | 2003 | 140 |
| 4 | 2017 | 88 | |
| 5 | 2005 | 83 | |
| 6 | 2004 | 82 | |
| 7 | 2021 | 82 | |
| 8 | Flavopiridol enhances human tumor cell radiosensitivity and prolongs expression of gammaH2AX foci. | 2004 | 37 |
| 9 | 2004 | 33 | |
| 10 | 2004 | 30 | |
| 11 | 2014 | 12 | |
| 12 | The effects of simvastatin on the pharmacokinectics of sitagliptin. | 2012 | 8 |
| 13 | 2020 | 2 |
About Michael A. Cerra
Michael A. Cerra is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Cancer Research, having authored 13 papers that have together received 968 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), DNA Repair Mechanisms (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Epigenetics and DNA Methylation (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers), Protein Degradation and Inhibitors (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and RNA modifications and cancer (1 paper). The work is most often cited by research in Genetics (169 citations), Hematology (117 citations), Internal Medicine (31 citations), Molecular Biology (600 citations) and Oncology (185 citations). Michael A. Cerra has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Philip J. Tofilon, William E. Burgan, Kevin A. Camphausen, Kelli A. Oswald, David Cerna, Jeffery Scott Russell, Jane B. Trepel, Min-Jung Lee, Mary T. Sproull and Tamalee Scott. Their work appears in journals such as Clinical Cancer Research, Molecular Cancer Therapeutics, Antiviral Therapy, Cancer Research and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.